COUNTRY-SPECIFIC DRIVERS AND BARRIERS FOR MARKET ACCESS OF E-HEALTH SOLUTIONS

Author(s)

Kloc K1, Lach S1, Dusza M1, Rémuzat C2, Sediri Y3, Palencia R4, Abshagen D4, Toumi M5
1Creativ-Ceutical, Krakow, Poland, 2Creativ-Ceutical, Paris, France, 3Creativ-Ceutical, Tunis, Tunisia, 4Merck KGaA, Darmstadt, Germany, 5Aix Marseille University, Marseille, France

OBJECTIVES: eHealth solutions emerged as promising innovations enhancing care over patients and enabling efficient delivery of healthcare services. The aim of this study was to assess current country-specific opportunities and challenges for market access of eHealth solutions in France, Germany, Italy, Spain, the United Kingdom, Canada and the United States.

METHODS: A targeted literature review was performed in Medline and Embase, complemented by ad-hoc and primary search with eHealth experts and payers.

RESULTS: Study findings revealed varying level of eHealth implementation across analysed countries, rated in 6-point scale as 2 in Germany, through 2.4 to 2.7 in the US, Canada, UK, Italy, 3 in France, and 3.3 in Spain.

Key barriers for adoption of eHealth solutions are associated with the immaturity of funding paths and scarcity of nation-wide, sustainable funding opportunities. eHealth is usually funded under pilot programs conducted at local and regional levels, and funding paths are not well defined. In Canada, Spain and Italy, system decentralization hampers expansion of solutions across country. In the US and Germany, payers and clinicians may express resistance to eHealth, since many programs failed to show benefits, and it is considered as disrupting current clinical practice.

Adoption of eHealth solutions is mainly driven by governmental initiatives and reforms. Canada and the UK have established numerous organizations supporting digital healthcare transformation and adoption of eHealth. France introduced legislative provisions for telemedicine and developed guidelines facilitating assessment of eHealth solutions. Innovative care and payment models are also drivers for digital technologies, as they emerge in the US and could be explored in France through new regulations and in Spain at local level.

CONCLUSIONS: Despite advances of eHealth solutions, their wide utilization and adoption is impeded, encountering country-specific hurdles. Clear regulatory and funding frameworks, standard interoperability and early cooperation of stakeholders along solution development may positively impact eHealth market access.

Conference/Value in Health Info

2018-11, ISPOR Europe 2018, Barcelona, Spain

Value in Health, Vol. 21, S3 (October 2018)

Code

PHP70

Topic

Health Policy & Regulatory, Health Service Delivery & Process of Care, Health Technology Assessment

Topic Subcategory

Approval & Labeling, Decision & Deliberative Processes, Formulary Development, Hospital and Clinical Practices, Pricing Policy & Schemes, Reimbursement & Access Policy

Disease

Multiple Diseases

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×